Circulating tumor DNA is a prognostic biomarker in metastatic melanoma patients treated with chemoimmunotherapy and BRAF inhibitor

Kalle E. Mattila; Siru Makela; Soili Kytölä; Emma Andersson; Pia Vihinen; Susan Ramadan; Tanja Skyttä; Leena Tiainen; Meri-Sisko Vuoristo; Kristiina Tyynela-Korhonen; Jussi Koivunen; Laura Kohtamäki; Kristiina Aittomäki; Micaela Hernberg

doi:10.1080/0284186X.2022.2137693

Circulating tumor DNA is a prognostic biomarker in metastatic melanoma patients treated with chemoimmunotherapy and BRAF inhibitor

Kalle E. Mattila, Siru Makela, Soili Kytölä, Emma Andersson, Pia Vihinen, Susan Ramadan, Tanja Skyttä, Leena Tiainen, Meri-Sisko Vuoristo, Kristiina Tyynela-Korhonen, Jussi Koivunen, Laura Kohtamäki, Kristiina Aittomäki, Micaela Hernberg

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Originalspråk	engelska
Tidskrift	Acta Oncologica
Volym	61
Nummer	10
Sidor (från-till)	1263-1267
Antal sidor	5
ISSN	0284-186X
DOI	https://doi.org/10.1080/0284186X.2022.2137693
Status	Publicerad - 3 okt. 2022
MoE-publikationstyp	A1 Tidskriftsartikel-refererad

Vetenskapsgrenar

3122 Cancersjukdomar

Åtkomst av dokument

10.1080/0284186X.2022.2137693

Citera det här

Mattila, K. E., Makela, S., Kytölä, S., Andersson, E., Vihinen, P., Ramadan, S., Skyttä, T., Tiainen, L., Vuoristo, M.-S., Tyynela-Korhonen, K., Koivunen, J., Kohtamäki, L., Aittomäki, K., & Hernberg, M. (2022). Circulating tumor DNA is a prognostic biomarker in metastatic melanoma patients treated with chemoimmunotherapy and BRAF inhibitor. Acta Oncologica, 61(10), 1263-1267. https://doi.org/10.1080/0284186X.2022.2137693

@article{5f423148ec99429395dd1f2c984060e4,

title = "Circulating tumor DNA is a prognostic biomarker in metastatic melanoma patients treated with chemoimmunotherapy and BRAF inhibitor",

keywords = "Biomarker, ctDNA, droplet digital PCR, Melanoma, Survival, 3122 Cancers",

author = "Mattila, {Kalle E.} and Siru Makela and Soili Kyt{\"o}l{\"a} and Emma Andersson and Pia Vihinen and Susan Ramadan and Tanja Skytt{\"a} and Leena Tiainen and Meri-Sisko Vuoristo and Kristiina Tyynela-Korhonen and Jussi Koivunen and Laura Kohtam{\"a}ki and Kristiina Aittom{\"a}ki and Micaela Hernberg",

year = "2022",

month = oct,

day = "3",

doi = "10.1080/0284186X.2022.2137693",

language = "English",

volume = "61",

pages = "1263--1267",

journal = "Acta Oncologica",

issn = "0284-186X",

publisher = "Medical Journals Sweden AB",

number = "10",

}

Mattila, KE, Makela, S, Kytölä, S , Andersson, E, Vihinen, P, Ramadan, S, Skyttä, T, Tiainen, L, Vuoristo, M-S, Tyynela-Korhonen, K, Koivunen, J, Kohtamäki, L , Aittomäki, K & Hernberg, M 2022, 'Circulating tumor DNA is a prognostic biomarker in metastatic melanoma patients treated with chemoimmunotherapy and BRAF inhibitor', Acta Oncologica, vol. 61, nr. 10, s. 1263-1267. https://doi.org/10.1080/0284186X.2022.2137693

TY - JOUR

T1 - Circulating tumor DNA is a prognostic biomarker in metastatic melanoma patients treated with chemoimmunotherapy and BRAF inhibitor

AU - Mattila, Kalle E.

AU - Makela, Siru

AU - Kytölä, Soili

AU - Andersson, Emma

AU - Vihinen, Pia

AU - Ramadan, Susan

AU - Skyttä, Tanja

AU - Tiainen, Leena

AU - Vuoristo, Meri-Sisko

AU - Tyynela-Korhonen, Kristiina

AU - Koivunen, Jussi

AU - Kohtamäki, Laura

AU - Aittomäki, Kristiina

AU - Hernberg, Micaela

PY - 2022/10/3

Y1 - 2022/10/3

KW - Biomarker

KW - ctDNA

KW - droplet digital PCR

KW - Melanoma

KW - Survival

KW - 3122 Cancers

U2 - 10.1080/0284186X.2022.2137693

DO - 10.1080/0284186X.2022.2137693

M3 - Article

C2 - 36307938

SN - 0284-186X

VL - 61

SP - 1263

EP - 1267

JO - Acta Oncologica

JF - Acta Oncologica

IS - 10

ER -